Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
Purchase Benefits
What is included with this book?
Protection Reactions | |
General Considerations | |
Alpha-Amino Protection (Nalpha-Protection) | |
Carboxy Protection | |
Side Chain Protection | |
Photocleavable Protections | |
Conclusion | |
Experimental Section | |
The Huisgen Cycloaddition in Peptidomimetic Chemistry | |
Introduction | |
The Huisgen [2+3] Cycloaddition Between Azides and Acetylenes | |
Mechanistic Consideration for the Cu-Huisgen and Ru-Huisgen Cycloaddition | |
Building Blocks for the Synthesis of Triazole Modified Peptidomimetics | |
Cyclic Triazole Peptidomimetics | |
Acylic Triazole Peptidomimetics | |
Useful Experimental Procedures | |
Recent Advances in Beta-Strand Mimetics | |
Introduction | |
Macrocyclic Peptidomimetics | |
Acyclic Compounds | |
Aliphatic and Aromatic Carbocycles | |
Ligands Containing One Ring or Multiple Rings with One Heteroatom (O, S) | |
Ligands Containing One Ring with Two Heteroatoms (N,N) | |
Ligands Containing One Ring with Two Heteroatoms (N,S) or Three Heteroatoms (N,N,S or N,N,N) | |
Ligands Containing Two Rings with One Heteroatom (N or O) | |
Ligands Containing Two Rings with Two or Three Heteroatoms (N,N or N,S or N,N,N) | |
Concluding Remarks | |
Medicinal Chemistry of Alpha-Amino Acids | |
Introduction | |
Glutamic Acid | |
Conformational Restriction | |
Bioisosterism | |
Structure-Activity-Studies | |
Conclusion | |
Medicinal Chemistry of Alicyclic Beta-Amino Acids | |
Introduction | |
Five-Membered Alicyclic Beta-Amino Acids | |
Six-Membered Alicyclic Beta-Amino Acids | |
medicinal Chemistry of Alpha-Hydroxy-Beta-Amino Acids | |
Introduction | |
Alpha-Hydroxy-Beta-Amino Acids | |
Antibacterial Agents | |
Inhibitors of Aminopeptidases | |
Aspartyl Proteases Inhibitors | |
Paclitaxel and its Derivatives | |
Peptide Drugs | |
Lights and Shades of Peptide and Protein Drugs | |
Peptide Drugs Available on the Market | |
Approved Peptides in Oncology | |
Antimicrobial Peptides | |
Perspectives | |
Oral Bioavailability of Peptide and Peptidomimetic Drugs | |
Introduction | |
Fundamental Considerations of Intestinal Absorption | |
Barriers Limiting Oral Peptide/Peptidomimetic Drugs Bioavailability | |
Strategies to Improve Peptide-Based Drugs Oral Bioavailability | |
Conclusions | |
Asymmetric Synthesis of Beta-Lactams Via the Staudinger Reaction | |
Introduction | |
The Staudinger Reaction | |
Influence of the Geometry of the Imine on Stereoselectivity in the Reaction | |
Influence of the Polarity of the Solvent on Stereoselectivity of the Reaction | |
Influence of the Isomerization of the Imine Prior to its Nucleophilic Attack onto the Ketene Stereoselectivity in the Reaction | |
Influence of the Order of Addition of the Reactants to the Reaction | |
Influence of Chiral Substituents on the Stereoselectivity of the Reaction | |
Asymmetric Induction from the Imine Component | |
Asymmetric Induction from the Ketene Component | |
Double Asymmetric Cycloinduction | |
Influence of Catalysts on the Stereoselectivity of the Reaction | |
Concluding Remarks | |
Advances in N- and O-Glycopeptide Synthesis - A Tool to Study Clycosylation and Develop New Therapeutics | |
Introduction | |
O-Glycopeptide Synthesis | |
Synthesis of Mucin Type Glycopeptides | |
Synthesis of Tumor-Associated Glycopeptides and Glycopeptide Vaccines | |
Synthesis of Tn, T, sialyl Tn, sialyl T Glycosylated Amino Acid Building Blocks | |
Synthesis of Tn, T, sialyl Tn, sialyl T Glycopeptides and Vaccines | |
Synthesis of Glycopeptide Recognition Domain of P-Selectin Glycoprotein Ligand 1 (PSGL-1) | |
Synthesis of a Core 2 sLe AMino Acid Building Block Including a sLe Mimic | |
Synthesis of Unsulfated and Sulfated Core 2 sLe and Core 2 sLe Mimic PSGL-1 Glycopeptides | |
Chemoenzymatic Synthesis of Unsulphated and Sulphated Sialyl Lewis PSGL-1 Glycopeptide | |
Synthesis of Other Types of O-Glycopeptides | |
Synthesis of Fmoc-GlcNAc-Ser/Thr Amino Acids | |
Synthesis of Estrogene Receptor Peptides for Conformational Analysis | |
Synthesis of N-Glycopeptides | |
Synthesis of Ribonuclease C (RNase C) Glycoprotein | |
Synthesis of Erythropoietin N-Glycopeptide Fragment 1-28 | |
Synthesis of Biantennary Dodecasaccharide | |
Synthesis of N-Glycopeptide Fragment 1-28 | |
Chemoenzymatic Synthesis of a HIV GP120 V3 Domain N-Glycopeptide | |
Synthesis of the Oxazoline Tetrasaccharide Donor | |
Synthesis of Fmoc-GlcNAc-Asn Amino Acid Building Block | |
Synthesis of V3 Cyclic GlcNAc Peptide and Endo A Coupling with Man3GlcNAc Oxazoline Donor | |
Recent Developments in Neoglycopeptide Synthesis | |
Introduction | |
Neoglycoside and Neoglycopeptide Synthesis | |
Protein Side-Chain Modifications | |
Cu-Catalyzed Azide-Alkyne "Click" Cycloaddition | |
Cross Metathesis | |
Application of Neoglycopeptides as Synthetic Vaccines | |
Enzymatic, Molecular and Cell Biological Techniques | |
Combinatorial/Library Peptide Synthesis | |
Introduction | |
High Throughput Synthesis of Peptides | |
Peptide Libraries | |
Future of Peptide Libraries | |
Synthetic Protocols | |
Table of Contents provided by Publisher. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.